The development of combination chemotherapy regimens for the treatment of advanced
Hodgkin's disease and aggressive non-Hodgkin's lymphoma are historical landmarks in …

Approximately 9000 new cases of Hodgkin lymphoma will be diagnosed in 2012,
representing 11% of all lymphomas in the USA. Although considered a highly curable …

In 1832, Thomas Hodgkin reported a remarkable clinical condition characterised by
enlargement of the lymph nodes and spleen, not compatible with known infectious …

This paper examines the evidence available to guide treatment decisions in three areas of
Hodgkin's lymphoma management. In Section I Dr. Evert Noordijk describes evolving …

The lymphomas are a diverse group of malignant disorders that vary with respect to their
molecular features, genetics, clinical presentation, treatment approaches, and outcome …

As a consequence of multiple trials, there are a variety of treatment options for Hodgkin's
disease and most of them appear relatively good. In other words, in many disease stages …

THE STEADY improvement in overall outcome for patients with Hodgkin's lymphoma has
become a proverbial example of the achievements of modern oncology. In the first 120 years …

Hodgkin lymphoma: differences and differential diagnosis Page 1 REVIEW ARTICLE www.journals.viamedica.pl/acta_haematologica_polonica
305305 Acta Haematologica Polonica 2021 Number 4, Volume 52, pages 305–308 DOI …

In den letzten zwei Jahrzehnten hat die Behandlung des Hodgkin-Lymphoms insbesondere
aufgrund der von Köln aus initiierten HD-Studien eine deutliche Differenzierung und …

HL is a malignancy arising from germinal centre or post-germinal centre B cells. The cancer
cells form a minority of the tumour and are surrounded by a reactive inflammatory milieu …